Burlington Northern Santa Fe Railway Company (BSNF) was formed on December 31, 1996 when Atchison, Topeka and Santa Fe Railway and Burlington Northern Railroad merged. It is the second largest rail system in the United States behind the Union Pacific. It owns and operates railroads in 27 states, primarily in the Western and Midwestern states, as well as a small number of tracks located in Canada. Due to the complexity of the business, Burlington Northern Santa Fe Railway is divided into 14 different divisions. These divisions are then repeatedly divided into smaller subdivisions. All of this was done to help resolve what could easily become a logistical nightmare. However, it was not a logistical nightmare that occurred, but a short but influential legal nightmare that finally befell the Burlington Northern Santa Fe Railway Company in early 2001. The Burlington Northern Santa Fe Railway was asked by the U.S. Equal Employment Opportunity Commission (EEOC) to "stop testing its employees for genetic abnormalities as part of a settlement for discrimination in the workplace”. (Schafer, 2001) This resulted from more than 30 employees being tested without their knowledge or consent that genetic testing was being performed using some of their blood samples provided during their medical exams. This is the first case brought against a company and a first in genetic testing. The medical examinations were conducted following complaints from employees of possible carpal tunnel syndrome (CTS) following the repeated work they performed in conjunction with their job or profession. These illnesses did not stem from previous medical problems as the company was secretly trying to discover. These complaints came from the worker after many years of work. The pressure and repeated movements experienced by their wrists while performing their specific profession have caused many of them excessive pain and suffering over the years. The company decided to send these employees for medical examinations through their own doctors. The company requested that they [doctors] take additional vials of blood to be tested for possible past genetic links to carpal tunnel syndrome. They were trying to link it to their employees' genes rather than accepting that employees acquired injuries while working for the company..